Market Cap (In CAD)
9.76 Million
Revenue (In CAD)
-
Net Income (In CAD)
-1.39 Million
Avg. Volume
52.38 Thousand
- Currency
- CAD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.04-0.105
- PE
- -
- EPS
- -
- Beta Value
- 0.3
- ISIN
- CA92918C1014
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Brent Willis Bsc.Eng
- Employee Count
- -
- Website
- https://voyageurpharmaceuticals.ca
- Ipo Date
- 2013-07-24
- Details
- Voyageur Pharmaceuticals Ltd. focuses on the development of active pharmaceutical ingredients minerals. The company intends to develop barium and iodine radiocontrast products and bromine based pharmaceutical products. It holds 100% interest in three barium sulfate deposits, including two properties suitable in grade for the pharmaceutical barite marketplace located in British Columbia, Canada; and interests in a high-grade iodine, lithium, and bromine brine project in Utah, the United States. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. is headquartered in Calgary, Canada.
More Stocks
-
THACKERThacker and Company Limited
THACKER
-
MG
-
LLCLendlease Group
LLC
-
WASWasko S.A.
WAS
-
VIRI
-
DODLADodla Dairy Limited
DODLA
-
SAFSafran SA
SAF
-
SCVPF